Breast Cancer Clinical Trial

AirXpanders AeroForm Tissue Expander System for Breast Reconstruction

Summary

This study is designed to allow existing investigators continued access to the AeroForm Tissue Expander to treat patients while AirXpanders completes a marketing application and during the review process by FDA.

View Full Description

Full Description

This is a prospective, multi-center, single arm, open-label, continued access clinical study. Subjects who meet the inclusion criteria and agree to participate in the study will be enrolled and implanted with the investigational AeroForm Tissue Expander. If the subject is having a bilateral procedure, the AeroForm expander will be implanted in each side. Subjects will be followed until the first post-operative visit after explant of the tissue expander(s) and exchange for permanent implant(s).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Subject is female between the ages of 18-70
Subject requires tissue expansion as part of breast reconstruction
Subject is able to provide written informed consent
Subject is able and willing to comply with all of the study requirements
Subject has the physical, perceptual and cognitive capacity to understand and manage the at home dosing regimen

Exclusion Criteria:

Subject's tissue integrity is unsuitable for tissue expansion
Subject has residual gross malignancy at the intended expansion site
Subject has current or prior infection at the intended expansion site
Subject has a history of failed tissue expansion or breast reconstruction
Subject has any co-morbid condition determined by the Investigator to place the subject at an increased risk of complications (e.g., severe collagen vascular disease, poorly managed diabetes)
Subject is taking any concomitant medications determined by the Investigator to place the subject at an increased risk of complications (e.g., Prednisone, Coumadin).

Study is for people with:

Breast Cancer

Estimated Enrollment:

50

Study ID:

NCT02504424

Recruitment Status:

Completed

Sponsor:

AirXpanders, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Marin General Hospital
Greenbrae California, 94904, United States
Good Samaritan Hospital, San Jose
San Jose California, 95008, United States
Broward Health Medical Center
Fort Lauderdale Florida, 33316, United States
Massachusetts General Hospital
Boston Massachusetts, 02114, United States
Faulkner Hospital
Boston Massachusetts, 02130, United States
University of Massachusetts Memorial Medical Center
Worcester Massachusetts, 01605, United States
Columbia University
New York New York, 10032, United States
Presbyterian Medical Center
Charlotte North Carolina, 28207, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

50

Study ID:

NCT02504424

Recruitment Status:

Completed

Sponsor:


AirXpanders, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.